Navigation Links
Onyx Pharmaceuticals Reports Third Quarter and Nine-Month 2008 Financial Results
Date:11/6/2008

as to explore in- licensing opportunities to grow Onyx strategically over time."

Net Revenue from Unconsolidated Joint Business

For the quarter ended September 30, 2008, Onyx reported net revenue from unconsolidated joint business of $39.9 million compared to $17.6 million for the same period in 2007. The increase in net revenue from unconsolidated joint business over the prior year is due to an increase in Nexavar revenue recognized by Bayer and royalty revenue offset by an increase in combined commercial and research and development expenses for Nexavar. The calculation of this line item is shown in the table following the Condensed Statement of Operations.

Operating Expenses

In the third quarter of 2008, Onyx recorded research and development expenses of $11.0 million, an increase of $3.0 million over the third quarter of 2007. The increase in expenses incurred in the third quarter of 2008 was primarily due to higher costs incurred for the development of Nexavar in breast cancer. Research and development expenses included $0.7 million of employee stock-based compensation for the third quarter of 2008 compared to $0.8 million for the third quarter of 2007.

In the third quarter of 2008, selling, general and administrative expenses were $19.3 million, an increase of $4.1 million over the third quarter of 2007. The increase in selling, general and administrative expenses was primarily due to increased employee-related expenses to support Nexavar. Selling, general and administrative expenses included $3.6 million of employee stock-based compensation in the third quarter of 2008 compared to $2.9 million for the third quarter of 2007.

Cash, Cash Equivalents and Marketable Securities

At September 30, 2008, the company had cash, cash equivalents, and current and noncurrent marketable securities of $488.2 million compared to $469.7 million at December 31, 2007. This increase was primarily due to cash provided by operations.
'/>"/>

SOURCE Onyx Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine news :

1. MiddleBrook Pharmaceuticals Announces Orange Book Listing of Moxatag(TM) Patents
2. Webcast Alert: Isis Pharmaceuticals Cardiovascular Program Review
3. Alseres Pharmaceuticals, Inc. to Present at Rodman & Renshaw 10th Annual Healthcare Conference
4. Lotus Pharmaceuticals to Present at Rodman & Renshaw Conference
5. Jazz Pharmaceuticals to Present at Investor Conferences
6. Rib-X Pharmaceuticals, Inc. to Present at the Rodman & Renshaw 10th Annual Healthcare Conference
7. Trubion Pharmaceuticals Provides Announcement Dates for Third-Quarter and Nine Months Earnings Conference Call
8. MiddleBrook Pharmaceuticals Retains National Account Firm VCG & Associates
9. Pacira Pharmaceuticals Leverages TalentManager(R) from Salary.Com(TM) to Integrate Compensation and Performance Management Processes
10. Genesis Pharmaceuticals Files Counter Claims
11. Arena Pharmaceuticals Announces Third Quarter 2008 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/1/2015)... ... ... Brig and Lita Hart, icons of the network marketing industry and founders of ... the HOPE Movement of EvolvHealth. In what has been a long-term relationship between the ... their missions of purpose together to change the course of the network marketing industry. ...
(Date:8/1/2015)... ... August 01, 2015 , ... “ reTXT ” was featured on NewsWatch ... coolest applications on the market for iOS, Android, and Windows. Joe Toohey, the host ... users to clarify, edit and delete any message including ones already sent. , While ...
(Date:7/31/2015)... ... August 01, 2015 , ... The Honor Society of Nursing, Sigma ... the Future of Nursing (GAPFON) 20-21 July 2015 in San Juan, Puerto Rico. Key ... meeting. , Dr. Silvia Cassiani, Advisor, Nursing and Allied Health Personnel Development, Unit of ...
(Date:7/31/2015)... (PRWEB) , ... July 31, 2015 , ... ... its new store run by GoodThreads. The store can be accessed by visiting ... designs, many of which are customizable. The best part: whenever a product is ...
(Date:7/31/2015)... (PRWEB) , ... July 31, 2015 , ... ... communicate. Rally Insurance Group, Inc. has re-branded their social media profiles to better ... personal way for consumers to communicate, find information, share insights and opinions. The ...
Breaking Medicine News(10 mins):Health News:Looking for HOPE? Healthy Home Has Evolv’d 2Health News:Looking for HOPE? Healthy Home Has Evolv’d 3Health News:Correct Auto-Correct and Clarify the Unclear with reTXT Messaging App 2Health News:Key Latin American Nurse Leaders Identify Regional Issues During Global Advisory Panel on the Future of Nursing Meeting 2Health News:Key Latin American Nurse Leaders Identify Regional Issues During Global Advisory Panel on the Future of Nursing Meeting 3Health News:Key Latin American Nurse Leaders Identify Regional Issues During Global Advisory Panel on the Future of Nursing Meeting 4Health News:Mesothelioma Organization Launches New Store 2Health News:Mesothelioma Organization Launches New Store 3Health News:Rally Insurance Group, Inc. Connects to Customers Through Re-branded Social Media Profiles 2
... Towards the Electronic,Patient Record (TEPR) -- ... today its next-generation interface terminology delivery service.,The ... to all of,IMO,s terminology knowledge sources. The ... for millisecond response times in a highly,scalable ...
... The Natural Marketing,Institute,s (NMI) Health & Wellness ... to suffer from digestive disorders than men. No ... hormones, stress, diet, or all,three., Preliminary research ... gastrointestinal problems. The studies show transit time,slows significantly ...
... Doctors and Women, WASHINGTON, May 19 A new ... less likely than,men to be treated with medications to prevent ... for women with heart,disease -- is calling on doctors to ... care that they need., "This study should serve as ...
... studies in 15 Finnish families have shown that ... aptitude. Musical aptitude was determined using three tests: ... test), and the Seashore pitch and time discrimination ... genetic study that aims in the identification of ...
... Fund has announced the 2008 recipients of the Career Awards ... Medical Scientists program is the result of the reformulation of ... by BWF in 1995 and ran through the 2006 award ... Independence program, which was modeled after the CABS award, BWF ...
... New Delhi and Singapore (May 14, 2008) ... announced its continued expansion in medical publishing with ... & Vascular Disease and Journal of the Renin-Angiotensin-Aldosterone ... British Journal of Diabetes & Vascular Disease (BJDVD) ...
Cached Medicine News:Health News:Intelligent Medical Objects (IMO), Inc. announces the General Availability of Its Terminology Portal Service for EMR/EHR and Charge-Capture Applications 2Health News:Intelligent Medical Objects (IMO), Inc. announces the General Availability of Its Terminology Portal Service for EMR/EHR and Charge-Capture Applications 3Health News:Intelligent Medical Objects (IMO), Inc. announces the General Availability of Its Terminology Portal Service for EMR/EHR and Charge-Capture Applications 4Health News:Women's Health Crisis: GI Problems Common in Women 2Health News:Study: Doctors Significantly Less Likely to Provide Women with Treatments to Prevent Heart Attacks 2Health News:BWF awards $11.2 million to support physician-scientists 2Health News:BWF awards $11.2 million to support physician-scientists 3Health News:SAGE acquires 2 new medical journals 2
(Date:7/30/2015)... CHENGDU, China , July 30, 2015 ... "Company"), a pharmaceutical company that specializes in the patented ... active pharmaceutical ingredients (API), provided updates regarding the notice ... MKT LLC (the "Exchange") indicating that the Company was ... set forth in Sections 134 and 1101 of the ...
(Date:7/30/2015)... N.J. , July 30, 2015 Eisai ... in the United States , European ... FDA, EMA and MHLW, respectively) for eribulin, for the ... who have received prior chemotherapy for advanced or metastatic ... on data from a pivotal global Phase 3 clinical ...
(Date:7/30/2015)... 2015 Future Market Insights (FMI) ... Glucose Monitoring Systems Market: Global Industry Analysis and Opportunity ... global continuous glucose monitoring systems market was valued at ... reach US$ 788.4 Mn by 2020, registering a CAGR ... Global continuous glucose monitoring systems market is ...
Breaking Medicine Technology:TPI Provides Update Regarding Non-Compliance with NYSE MKT Continued Listing Requirements 2Eisai Submits Simultaneous Regulatory Applications for Eribulin in Soft Tissue Sarcoma in the United States, European Union and Japan 2Eisai Submits Simultaneous Regulatory Applications for Eribulin in Soft Tissue Sarcoma in the United States, European Union and Japan 3Eisai Submits Simultaneous Regulatory Applications for Eribulin in Soft Tissue Sarcoma in the United States, European Union and Japan 4Eisai Submits Simultaneous Regulatory Applications for Eribulin in Soft Tissue Sarcoma in the United States, European Union and Japan 5Global Continuous Glucose Monitoring (CGM) Systems Market: Transmitters and Monitors Most Dominant Segment, Says Future Market Insights 2Global Continuous Glucose Monitoring (CGM) Systems Market: Transmitters and Monitors Most Dominant Segment, Says Future Market Insights 3Global Continuous Glucose Monitoring (CGM) Systems Market: Transmitters and Monitors Most Dominant Segment, Says Future Market Insights 4
... AcelRx Pharmaceuticals, Inc. announced today that it has filed ... and Exchange Commission (SEC) relating to a proposed initial public ... the common stock to be sold in the offering will ... Co. is acting as sole book-running manager. Canaccord Genuity Inc., ...
... Nov. 12, 2010 WebMD Health Corp. (Nasdaq: ... will deliver a presentation at the Citi 7th Annual U.S. ... p.m. ET and Anthony Vuolo, COO and CFO, will join ... analysts and the general public are invited to listen to ...
Cached Medicine Technology:
... Cement consists of a two ... bone cement liquid within a ... polyethylene bag,containing bone cement powder ... interiors of the blister pack,and ...
A low viscosity type of bone cement, intended for syringe or cement gun application....
A "doughy" type of bone cement intended for manual application....
High viscosity bone cement without antibiotics for digital use with an average setting time of approx. 6-8 Min., 40g of powder and 14.4g of liquid....
Medicine Products: